AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Metoclopramide in South Africa
6 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MAXOLON S5 | H/5.7.2/200 | Pharmaco Distribution (Pty) Ltd | suspended | 1 Jun 2022 |
| MAXOLON S10 | H/5.7.2/201 | Pharmaco Distribution (Pty) Ltd | suspended | 1 Jun 2022 |
| PRIMPERAN SUPPOSITORIES (PAEDIATRIC) | F/5.7.2/113 | Roche Products (Pty) Ltd | suspended | 25 May 2022 |
| PRIMPERAN SUPPOSITORIES (ADULT) | F/5.7.2/114 | Roche Products (Pty) Ltd | suspended | 25 May 2022 |
| CLOPAMON SUPPOSITORIES 5 mg | M/5.7.2/190 | Adcock Ingram Limited | active | 1 Jan 1900 |
| CLOPAMON SUPPOSITORIES 10 mg | M/5.7.2/191 | Adcock Ingram Limited | active | 1 Jan 1900 |
Metoclopramide — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Metoclopramide, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Metoclopramide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.